Sengenics believes that forging strong external alliances is an essential part of our strategy to access great science. Sengenics is pursuing potential collaborators for early stage opportunities in order to identify and develop innovative products in the following areas of interest:

Cancer

Autoimmune

Infectious

Neuro

Vaccines

Transplants

Autism

iTAP

The KREX™ Technology Accesss Programme (iTAP) is primarily targeted at pharmaceutical and biotechnology companies to rapidly enhance and grow their biomarker, drug and diagnostic discovery portfolios in a deep collaborative fashion by fully leveraging Sengenics’ Immunome protein array technology.

On-site support and code-level access to data analysis pipelines

License with open right to use, commercialise and patent discoveries

ITAP

Immunome Technology Accesss Programme

70% subsidy on the cost of Immunome arrays & associated reagents

Full access to the sengenics R&D team

BUSINESS DEVELOPMENT

We’d love to hear more about your work and perspective. Let’s start a conversation by filling up the form below:





Name:

Institution:

Contact Number:

Email:


Message:

SUBMIT
SUBMIT

X